DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $62,098,000 | -46.0% | 3,080,237 | 0.0% | 3.85% | -48.9% |
Q2 2021 | $114,954,000 | +46.0% | 3,080,237 | 0.0% | 7.53% | +68.8% |
Q1 2021 | $78,762,000 | +16.1% | 3,080,237 | 0.0% | 4.46% | +4.7% |
Q4 2020 | $67,858,000 | -7.6% | 3,080,237 | -24.5% | 4.26% | -37.7% |
Q3 2020 | $73,403,000 | -29.2% | 4,080,237 | 0.0% | 6.84% | -37.0% |
Q2 2020 | $103,638,000 | +38.3% | 4,080,237 | 0.0% | 10.86% | -14.4% |
Q1 2020 | $74,954,000 | -16.6% | 4,080,237 | 0.0% | 12.68% | -5.4% |
Q4 2019 | $89,888,000 | -14.6% | 4,080,237 | -44.3% | 13.40% | -50.5% |
Q3 2019 | $105,262,000 | -8.8% | 7,330,237 | 0.0% | 27.10% | -53.8% |
Q2 2019 | $115,451,000 | -11.8% | 7,330,237 | -17.9% | 58.64% | +12.1% |
Q1 2019 | $130,828,000 | +37.0% | 8,930,237 | 0.0% | 52.31% | +60.3% |
Q4 2018 | $95,464,000 | -29.9% | 8,930,237 | 0.0% | 32.62% | +5.5% |
Q3 2018 | $136,275,000 | +24.6% | 8,930,237 | 0.0% | 30.93% | -9.8% |
Q2 2018 | $109,395,000 | +28.1% | 8,930,237 | 0.0% | 34.28% | -31.9% |
Q1 2018 | $85,373,000 | +5.9% | 8,930,237 | 0.0% | 50.34% | -4.9% |
Q4 2017 | $80,640,000 | – | 8,930,237 | – | 52.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|